Literature DB >> 30103330

Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.

Jenalle E Baker1,2, Yen Ying Lim1, Judith Jaeger3,4, David Ames5,6, Nicola T Lautenschlager6, Joanne Robertson1, Robert H Pietrzak7,8, Peter J Snyder9, Victor L Villemagne1,10,11, Christopher C Rowe10,11, Colin L Masters1, Paul Maruff1,12.   

Abstract

Recent meta-analyses suggest that episodic memory impairment associated with preclinical Alzheimer's disease (AD) equates to 0.15-0.24 standard deviations below that of cognitively healthy older adults. The current study aimed to characterize impairments in verbal acquisition and recall detectable at a single assessment, and investigate how verbal learning and episodic memory deteriorates in preclinical AD. A verbal list-learning task, the International Shopping List Test (ISLT), was administered multiple times over an 18-month period, to three groups of participants: amyloid-beta negative healthy older adults (Aβ- CN; n = 50); Aβ+ positive healthy older adults (preclinical AD; n = 25); and Aβ+ positive individuals diagnosed with mild cognitive impairment (prodromal AD; n = 22). At baseline, there was no significant difference between the preclinical AD and control groups rate of acquisition, or total and delayed recall, however all indices were impaired in prodromal AD. Performance on ISLT total score improved in the control group over the 18-month period, but showed a moderate magnitude decline in the preclinical AD group (Cohen's d = - 0.63, [- 1.12, - 0.14]) and the prodromal AD group (Cohen's d = - 0.36, [- 0.94, 0.22]). No significant impairment in acquisition associated with preclinical AD was seen at baseline. Individuals with preclinical AD showed a significantly different performance on the ISLT total score over an 18-month period, compared to those without abnormal Aβ. Individuals with prodromal AD showed substantial impairment on the ISLT at baseline and declined to a greater extent over time.

Entities:  

Keywords:  Alzheimer’s disease; amyloid-β protein; cognitive decline; learning curve; memory and learning tests; mild cognitive impairment; neuropsychology; transfer of learning

Mesh:

Substances:

Year:  2018        PMID: 30103330     DOI: 10.3233/JAD-180344

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

1.  Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.

Authors:  Annie M Racine; Alexandra Touroutoglou; Tatiana Abrantes; Bonnie Wong; Tamara G Fong; Michele Cavallari; Thomas G Travison; Yun Gou; Edward R Marcantonio; David C Alsop; Richard N Jones; Sharon K Inouye; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment.

Authors:  Nikki H Stricker; Emily S Lundt; Sabrina M Albertson; Mary M Machulda; Shehroo B Pudumjee; Walter K Kremers; Clifford R Jack; David S Knopman; Ronald C Petersen; Michelle M Mielke
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Practical algorithms for amyloid β probability in subjective or mild cognitive impairment.

Authors:  Nancy Maserejian; Shijia Bian; Wenting Wang; Judith Jaeger; Jeremy A Syrjanen; Jeremiah Aakre; Clifford R Jack; Michelle M Mielke; Feng Gao
Journal:  Alzheimers Dement (Amst)       Date:  2019-10-22

4.  Validation and Normative Data of the Spanish Version of the Rey Auditory Verbal Learning Test and Associated Long-Term Forgetting Measures in Middle-Aged Adults.

Authors:  Vanessa Alviarez-Schulze; Gabriele Cattaneo; Catherine Pachón-García; Javier Solana-Sánchez; Josep M Tormos; Alvaro Pascual-Leone; David Bartrés-Faz
Journal:  Front Aging Neurosci       Date:  2022-02-09       Impact factor: 5.750

5.  A cross-sectional study in healthy elderly subjects aimed at development of an algorithm to increase identification of Alzheimer pathology for the purpose of clinical trial participation.

Authors:  Samantha Prins; Ahnjili Zhuparris; Ellen P Hart; Robert-Jan Doll; Geert Jan Groeneveld
Journal:  Alzheimers Res Ther       Date:  2021-07-17       Impact factor: 6.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.